A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALK-rearrangement who treated with erlotinib and crizotinib
Artaç, Mehmet, Korkmaz, Levent, Karaağaç, Mustafa, Kaya, Buğra, Poyraz, Necdet, Özön, Hakan, Er, Zehra, Tavlı, LemaVolume:
4
Language:
english
Journal:
Journal of Oncological Sciences
DOI:
10.1016/j.jons.2018.04.001
Date:
August, 2018
File:
PDF, 465 KB
english, 2018